BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11393328)

  • 1. Tourette syndrome: clinical characteristics and current management strategies.
    Kossoff EH; Singer HS
    Paediatr Drugs; 2001; 3(5):355-63. PubMed ID: 11393328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies.
    Roth J
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S75-S79. PubMed ID: 28807495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological options for the treatment of Tourette's disorder.
    Jiménez-Jiménez FJ; García-Ruiz PJ
    Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.
    Egolf A; Coffey BJ
    Drugs Today (Barc); 2014 Feb; 50(2):159-79. PubMed ID: 24619591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tics in Tourette syndrome: new treatment options.
    Awaad Y
    J Child Neurol; 1999 May; 14(5):316-9. PubMed ID: 10342599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of Tourette's syndrome and associated disorders.
    Cohen DJ; Riddle MA; Leckman JF
    Psychiatr Clin North Am; 1992 Mar; 15(1):109-29. PubMed ID: 1549543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between tic medication therapy and psychiatric comorbidities among patients with Tourette syndrome: A national population-based study in Taiwan.
    Chen CW; Hsueh CW; Chung CH; Wang HS; Chang HJ; Chien WC
    Brain Dev; 2020 May; 42(5):373-382. PubMed ID: 32029325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs in Tourette syndrome.
    Silay YS; Jankovic J
    Expert Opin Emerg Drugs; 2005 May; 10(2):365-80. PubMed ID: 15934872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatment strategies in Tourette syndrome: what's in the pipeline?
    Termine C; Selvini C; Rossi G; Balottin U
    Int Rev Neurobiol; 2013; 112():445-80. PubMed ID: 24295630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD; Fox SH
    Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tic syndrome].
    Czapliński A; Steck AJ; Fuhr P
    Neurol Neurochir Pol; 2002; 36(3):493-504. PubMed ID: 12185806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tourette syndrome: an analysis of its comorbidity and specific treatment].
    Castellanos FX; Acosta MT
    Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of tics in Tourette syndrome with atypical antipsychotic drugs].
    Sindø I; Jørgensen JI
    Ugeskr Laeger; 2002 Aug; 164(32):3755-9. PubMed ID: 12362607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tics.
    Pringsheim T; Davenport WJ; Lang A
    Curr Opin Neurol; 2003 Aug; 16(4):523-7. PubMed ID: 12869813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tics and its disorders.
    Marcus D; Kurlan R
    Neurol Clin; 2001 Aug; 19(3):735-58, viii. PubMed ID: 11532652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review.
    Besag FM; Vasey MJ; Lao KS; Chowdhury U; Stern JS
    J Psychopharmacol; 2021 Sep; 35(9):1037-1061. PubMed ID: 34286606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tourette syndrome, associated conditions and the complexities of treatment.
    Robertson MM
    Brain; 2000 Mar; 123 Pt 3():425-62. PubMed ID: 10686169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.